Horny goat weed for erections: animal mechanisms are not human treatment evidence
Icariin has produced erectile and tissue effects in laboratory models, but high-quality human trials of horny goat weed for ED are still missing.
Icariin has produced erectile and tissue effects in laboratory models, but high-quality human trials of horny goat weed for ED are still missing.
In a multicenter randomized trial, antioxidant supplementation did not improve semen measures, pregnancy, or live birth in male-factor infertility.
Human studies focus on infertility biomarkers, while libido claims often rely on rat experiments. Neither establishes erectile-function treatment.
A randomized trial reported benefits for one proprietary multi-herb formula, but the design cannot isolate ingredients or support unrelated blends.
A marketplace analysis found limited human evidence and large drops in favorable review claims after filtering potentially unreliable comments.
Researchers have identified more than 100 unapproved PDE5-related adulterants, complicating routine screening of sexual-enhancement supplements.
Controlled studies found no testosterone, body-composition, strength, or training advantage from ZMA in zinc-sufficient exercising men.
Small studies tested acetyl- and propionyl-L-carnitine with prescription ED medicines in selected patients—not carnitine alone for general use.
Trials in hypertensive and infertile men produced limited or null erectile-function findings, so CoQ10 should not be sold as established ED treatment.
A folic-acid trial added the vitamin to tadalafil in men with diabetes. That result cannot establish folic acid alone as an ED treatment.
Early enthusiasm for ginkgo and antidepressant-related sexual dysfunction was not reproduced in two randomized placebo-controlled trials.
A placebo-controlled niacin trial found a limited signal in men with ED and dyslipidemia, but its medical-level dose carries important safety concerns.